Canadian partner for research program

A new clinical research program has been launched in Israel that will trial cannabinoid-based IBD treatment and other products from Israel’s SciCann. The program partners SciCann with Canada’s FSD and Mor – the technology transfer arm of Israel’s Clalit HealthCare.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *